Craniomaxillofacial Devices Market to Reach USD 3.7 Bn by 2035

According to analysts at Vantage Market Research, the Global Craniomaxillofacial Devices Market size is worth USD 1.9 Billion in 2024 and is projected to reach USD 3.7 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 8.7% from 2024 to 2032. Key trends include advancements in 3D printing, adoption of bioresorbable implants, rising trauma cases, increasing cosmetic surgeries, and growing demand for personalized and minimally invasive solutions.

Market Overview

The growing preference for minimally invasive trauma reconstruction procedures over traditional methods is expected to drive demand and adoption of craniomaxillofacial surgeries, thereby accelerating industry growth. According to recent research, the introduction of minimally invasive surgical procedures, driven by patient-centric benefits and recognized healthcare cost savings, is bolstering advancements in craniomaxillofacial device manufacturing and surgical techniques. These technological advancements are poised to propel market growth in the coming years. However, the high costs associated with craniomaxillofacial devices and surgeries remain a significant barrier, particularly for patients in low- and middle-income countries, limiting market adoption in these regions.

The adoption of advanced technologies, such as robotic arm-assisted CMF surgeries and bioabsorbable implants for cranial fixation, is expected to significantly boost demand for CMF devices. Innovations like the increased use of virtual plating technology and the development of cost-effective thoracic fixation devices are further driving market growth, reflecting a strong trend toward technological advancement and affordability in the industry.

DePuy Synthes Launches the UNIUM™ System as a Next Generation Power Tools System for Trauma and Small Bone Procedures

• In November 2021, DePuy Synthes, Orthopaedics Company of Johnson & Johnson, has launched the UNIUM™ System as the newest addition to its Power Tools portfolio. The system is designed with a commitment to ergonomics, reliability and efficiency in the Trauma setting and can be used across small bone, sports medicine, spine and thorax procedures

Key Takeaways from the Report

• In 2024, North America dominated the market with 79.10% market share. The region owing to the availability of technologically advanced implants and increased volume of Craniomaxillofacial (CMF) procedures
• Based on the Product, the CMF Plate and Screw Fixation category accounted for significant market share of 73.20%. CMF Plate and Screw Fixation is used in various surgical procedures such as deformity correction, orthognathic surgery, tumor removal, and pediatric surgeries
• Based on the Material, the Metal category accounted for significant market share of 71.30%. The metal category Features such as lower corrosiveness, and ability to provide rigid support to the fractures
• Based on the Application, the Orthognathic and Dental Surgery category accounted for significant market share of 54.60%. The segment is driven by  increasing incidence of trauma and spinal disorders requiring Cerebrospinal Fluid (CSF) management during surgery

Top Companies

• Johnson & Johnson
• Stryker Corporation
• Medtronic
• Zimmer Bionet
• Aesculap Implants Systems
• Medartis AG
• Synimed
• DePuy Synthes
• Reni Shaw Plc

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest News

Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment

• In November 2024, Stryker is a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge management portfolio. Now integrated with Stryker’s Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals